cns Latest News

This event will discuss the latest developments in preclinical discover, clinical trial design, clinical trial management and the latest developments in neurodegenerative treatments and will feature talks from top pharmaceutical companies.

Paving the way of using AD biomarkers as supportive evidence of disease modifying treatment effects

SMi are proud to present their 7th annual ADMET conference on 9th & 10th July 2012 in London,

TCG Lifesciences Limited (TCGLS) has announced that it has entered into a strategic agreement with JSW Lifesciences (JSW), a full services EU based CRO, to strengthen its R&D offerings in the area of Central Nervous System (CNS).

Join fellow industry professionals at SMi's Masterclass - CNS Orphan Diseases - the alternative route in CNS taking place on 9th April 2013, Central London

Join fellow industry professionals at SMi's Masterclass - CNS Orphan Diseases- the alternative route in CNS taking place on 9th April 2013, Central London

This event will discuss the latest developments in preclinical discover, clinical trial design, clinical trial management and the latest developments in neurodegenerative treatments and will feature talks from top pharmaceutical companies.

Paving the way of using AD biomarkers as supportive evidence of disease modifying treatment effects

Join SMi at the 12th annual Pain Therapeutics conference, which will be held on 21st & 22nd May 2012 in London, UK.

SMi are proud to present their 7th annual ADMET conference on 9th & 10th July 2012 in London,

TCG Lifesciences Limited (TCGLS) has announced that it has entered into a strategic agreement with JSW Lifesciences (JSW), a full services EU based CRO, to strengthen its R&D offerings in the area of Central Nervous System (CNS).

A new report by London-based business information company visiongain predicts that world pharma clinical trial services revenues will reach $32.73bn in 2015. Revenues for those companies (CROs) totalled $21.69bn in 2010.

Recently published research from Business Insights, "The CNS Market Outlook to 2016", is now available at Fast Market Research

SMi Group is proud to announce its 10th annual Clinical Trials in CNS conference, which will be held in London on 23rd & 24th November 2011.

Fast Market Research recommends "Dementia Therapeutics - Pipeline Assessment and Market Forecasts to 2017" from GlobalData, now available

Identify the key issues responsible for the low success rates in CNS drug discovery and development, to highlight strategies being developed to overcome these issues and to discuss how these may change the landscape for drug development.

Insider Trading of Real Estate Sector Touched the Lowest Level of the Year

SMi Biomarkers - LAST CHANCE TO ATTEND! Dieses Bild im Großformat speichern (openPR) - Biomarkers Summit Biomarker Discovery, Validation and Qualification 31st January to 1st February 2011, Crowne Plaza - The City, London, United Kingdom

SMi's CPD accredited masterclass will be delivered through a combination of discussions, case studies and lectures, designed to promote a hands-on and creative approach to CNS medicines research, visit the corresponding link below to register online.

Recently published research from GlobalData, "Huntington's Disease - Pipeline Assessment and Market Forecasts to 2017", is now available at Fast Market Research

SMi present their 4th annual Biomarkers Summit Monday 31st January & Tuesday 1st February 2011, Crowne Plaza City, Central London, UK Sponsored by: Caprotec, Cell Signalling Technology, Genstruct, Millipore, RBM, Quest Diagnostics

Suicidality Monitoring in Clinical Trials will be one of the topics widely discussed at Optimising Clinical Development in CNS, taking place in London, 15-16 of March 2011.

Fast Market Research recommends "Insomnia - Pipeline Assessment and Market Forecasts to 2017" from GlobalData, now available

New Pharmaceuticals market report from GlobalData: "Major Depressive Disorder (MDD) - Pipeline Assessment and Market Forecasts to 2017"

SMi present their 4th annual... Biomarkers Summit Discovery, Validation and Qualification Monday 31st January & Tuesday 1st February 2011 Crowne Plaza City, Central London, UK Sponsored by: Caprotec Genstruct RBM

Bharatbook added a new report on "Central Nervous System (CNS) Biomarkers: Technologies and Global Markets" which assess the global CNS biomarker market and make forecasts from 2010 to 2015.

New Pharmaceuticals research report from GlobalData is now available from Fast Market Research

Monday 31st January & Tuesday 1st February 2011 Crown Plaza City, London, www.smi-online.co.uk/preclinical-biomarkers.asp

Schizophrenia played a prominent role at this year's American Psychiatric Association Annual Meeting due to the prevailing high level of unmet need.

Sanofi-Aventis has announced the withdrawal of its US and EU applications for the approval of eplivanserin as a treatment for patients with chronic insomnia characterized by difficulties with sleep maintenance.

Are you in need of a cnc plasma cutter? Are you not sure what cnc plasma cutter to buy? Perhaps you need plasma cutting equipment for a diy (do it yourself) project

Bharatbook.com added a new report on "The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis" gives clinical trials about CNS in pharma companies.

The blood-brain barrier (BBB) remains a major obstacle to the successful delivery of drugs to treat central nervous system (CNS) disorders, reports Genetic Engineering and Biotechnology News (GEN)